Home LiteratureArticle Details
PMID: 15684389 Published · ppublish English Journal Article

Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.

Molecular and cellular biology ·Vol. 25 ·No. 4 ·2005-02-00 ·Pages 1379-88

Salerno M, Palmieri D, Bouadis A, Halverson D, Steeg PS

Abstract

Metastatic disease is a significant contributor to cancer patient mortality. We previously reported that the Kinase Suppressor of Ras1 (KSR1) scaffold protein for the Erk mitogen-activated protein kinase pathway coimmunoprecipitated the metastasis suppressor protein Nm23-H1. We now hypothesize that altered expression levels of Nm23-H1 influence the binding properties, stability, and function of the KSR1 scaffold. Increased coimmunoprecipitation of Hsp90 with KSR1 was observed in either stable or transient transfectants of nm23-H1 in MDA-MB-435 human breast carcinoma cells. Similar trends were also observed in the cytoplasmic and nuclear fractions of cells. Cells expressing high levels of Nm23-H1 exhibited increased KSR1 degradation in the presence of either cycloheximide or an Hsp90-directed drug currently in clinical trial, 17-allylamino-17-demethoxygeldanamycin (17-AAG). In agreement with KSR1 degradation data, high-Nm23-H1-expression cells were preferentially inhibited in anchorage-independent colonization assays by 17-AAG. KSR1 scaffold binding patterns are dynamic in both the cytoplasmic and nuclear compartments, modulated by metastasis suppressor expression. Metastasis suppressor expression levels can impact traditional signaling pathways, such as the Erk pathway, resulting in altered tumor cell sensitivity to cancer therapeutics.

MeSH Terms
Benzoquinones Breast Neoplasms/metabolism Cell Fractionation Cell Nucleus/metabolism Cell Proliferation/drug effects Cycloheximide/pharmacology Cytoplasm/metabolism Extracellular Signal-Regulated MAP Kinases/metabolism Female Genes, Tumor Suppressor HSP90 Heat-Shock Proteins/metabolism Humans Lactams, Macrocyclic NM23 Nucleoside Diphosphate Kinases Nucleoside-Diphosphate Kinase/metabolism Protein Binding/drug effects,physiology Protein Denaturation/drug effects Protein Kinase Inhibitors/pharmacology Protein Kinases/metabolism Rifabutin/analogs & derivatives,pharmacology Signal Transduction/drug effects,physiology Tumor Cells, Cultured
Chemicals
Benzoquinones HSP90 Heat-Shock Proteins Lactams, Macrocyclic NM23 Nucleoside Diphosphate Kinases Protein Kinase Inhibitors Rifabutin tanespimycin Cycloheximide Protein Kinases KSR-1 protein kinase Extracellular Signal-Regulated MAP Kinases NME1 protein, human Nucleoside-Diphosphate Kinase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Salerno Massimiliano
Women's Cancers Section, Laboratory of Pathology, Building 10, Room 2A33, National Cancer Institute, Bethesda, MD 20892, USA. maxsal@mail.nih.gov
Palmieri Diane
Bouadis Amina
Halverson Douglas
Steeg Patricia S
References (81)
81 references, click to expand
  1. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro.
    Magn Reson Med. 1999 May;41(5):897-903 PMID: 10332871
  2. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.
    J Biol Chem. 2002 Oct 11;277(41):38197-204 PMID: 12145286
  3. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly.
    Nat Cell Biol. 2002 Dec;4(12):929-36 PMID: 12447393
  4. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.
    Nucleic Acids Res. 2002 Dec 15;30(24):5465-75 PMID: 12490715
  5. Metastasis suppressors alter the signal transduction of cancer cells.
    Nat Rev Cancer. 2003 Jan;3(1):55-63 PMID: 12509767
  6. Signal transduction--directed cancer treatments.
    Annu Rev Pharmacol Toxicol. 2003;43:199-231 PMID: 12195027
  7. Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Complex formation of NDPK B with Gbeta gamma dimers and phosphorylation of His-266 IN Gbeta.
    J Biol Chem. 2003 Feb 28;278(9):7220-6 PMID: 12486123
  8. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.
    Cell. 2003 Mar 7;112(5):659-72 PMID: 12628186
  9. Heat shock protein 90 as a molecular target for cancer therapeutics.
    Cancer Cell. 2003 Mar;3(3):213-7 PMID: 12676580
  10. Novel pharmacological approaches in the treatment of breast cancer.
    Expert Opin Investig Drugs. 2003 Jun;12(6):909-21 PMID: 12783596
  11. Multiple biochemical activities of NM23/NDP kinase in gene regulation.
    J Bioenerg Biomembr. 2003 Feb;35(1):31-40 PMID: 12848339
  12. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase.
    Cancer Res. 2003 Jul 15;63(14):4089-94 PMID: 12874011
  13. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Cancer Res. 2003 Jul 15;63(14):4232-8 PMID: 12874031
  14. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.
    Curr Biol. 2003 Aug 19;13(16):1356-64 PMID: 12932319
  15. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3763-72 PMID: 14506169
  16. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Cancer Res. 1995 May 1;55(9):1977-81 PMID: 7728768
  17. Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase.
    J Biol Chem. 1995 Sep 15;270(37):21758-64 PMID: 7665595
  18. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.
    Mol Cell Biol. 1999 Aug;19(8):5523-34 PMID: 10409742
  19. H-ras gene amplification or mutation is not common in human primary breast cancer.
    Oncol Rep. 1999 Sep-Oct;6(5):1029-33 PMID: 10425298
  20. Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade.
    Cell. 1999 Aug 20;98(4):501-12 PMID: 10481914
  21. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Am J Pathol. 1999 Sep;155(3):739-52 PMID: 10487832
  22. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer.
    Nat Med. 2003 Oct;9(10):1266-8 PMID: 12960962
  23. Escherichia coli nucleoside diphosphate kinase is a uracil-processing DNA repair nuclease.
    Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13247-52 PMID: 14585934
  24. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation.
    Int J Cancer. 2004 Jan 10;108(2):207-11 PMID: 14639604
  25. G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation.
    J Biol Chem. 2003 Dec 19;278(51):50908-14 PMID: 14557268
  26. Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase.
    EMBO J. 2004 Jan 14;23(1):111-9 PMID: 14685271
  27. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP.
    Nature. 2004 Jan 15;427(6971):256-60 PMID: 14724641
  28. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line.
    Cancer Res. 2004 May 15;64(10):3479-85 PMID: 15150101
  29. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
    Cell. 1991 Apr 5;65(1):25-35 PMID: 2013093
  30. Inhibition of cell motility after nm23 transfection of human and murine tumor cells.
    Cancer Res. 1993 May 1;53(9):1971-3 PMID: 8481897
  31. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
    Oncogene. 1993 Sep;8(9):2325-33 PMID: 8395676
  32. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.
    Int J Cancer. 1995 Jan 17;60(2):204-10 PMID: 7829217
  33. Evaluation of the expression levels of nm23-H1 mRNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue.
    Pathology. 1994 Oct;26(4):423-8 PMID: 7892043
  34. The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation.
    Exp Cell Res. 1995 Apr;217(2):267-71 PMID: 7698225
  35. Evidence for interaction between human PRUNE and nm23-H1 NDPKinase.
    Oncogene. 1999 Dec 2;18(51):7244-52 PMID: 10602478
  36. Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation.
    Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14911-8 PMID: 10611312
  37. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Clin Cancer Res. 1999 Dec;5(12):4301-7 PMID: 10632374
  38. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Cancer Res. 2000 Jan 15;60(2):342-9 PMID: 10667586
  39. Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319.
    Biochem J. 2000 Mar 15;346 Pt 3:623-30 PMID: 10698688
  40. Ras activation in human breast cancer.
    Breast Cancer Res Treat. 2000 Jul;62(1):51-62 PMID: 10989985
  41. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.
    Exp Cell Res. 2000 Nov 25;261(1):127-38 PMID: 11082283
  42. Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome.
    Exp Cell Res. 2001 Jan 15;262(2):145-53 PMID: 11139339
  43. Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin.
    Ann Thorac Surg. 2000 Dec;70(6):1853-60 PMID: 11156083
  44. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
    Cancer Res. 2001 Feb 1;61(3):963-9 PMID: 11221891
  45. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.
    Breast Cancer Res. 2000;2(6):417-22 PMID: 11250735
  46. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis.
    Nat Med. 2001 Mar;7(3):350-5 PMID: 11231635
  47. Kinase suppressor of Ras signals through Thr269 of c-Raf-1.
    J Biol Chem. 2001 Mar 30;276(13):9733-41 PMID: 11134016
  48. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
    Cancer Res. 2001 Mar 1;61(5):2071-9 PMID: 11280768
  49. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1.
    Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4385-90 PMID: 11274357
  50. KSR: a MAPK scaffold of the Ras pathway?
    J Cell Sci. 2001 May;114(Pt 9):1609-12 PMID: 11309192
  51. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.
    Br J Cancer. 2001 May 18;84(10):1424-31 PMID: 11355958
  52. The Ste5p scaffold.
    J Cell Sci. 2001 Nov;114(Pt 22):3967-78 PMID: 11739629
  53. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1.
    Mol Cell. 2001 Nov;8(5):983-93 PMID: 11741534
  54. HSP90 as a new therapeutic target for cancer therapy: the story unfolds.
    Expert Opin Biol Ther. 2002 Jan;2(1):3-24 PMID: 11772336
  55. Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras.
    J Biol Chem. 2002 Feb 15;277(7):5369-77 PMID: 11741955
  56. KSR is a scaffold required for activation of the ERK/MAPK module.
    Genes Dev. 2002 Feb 15;16(4):427-38 PMID: 11850406
  57. Critical contribution of linker proteins to Raf kinase activation.
    J Biol Chem. 2002 Feb 22;277(8):5940-3 PMID: 11741918
  58. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.
    Oncogene. 2002 Feb 14;21(8):1159-66 PMID: 11850835
  59. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation.
    Curr Biol. 2002 Mar 5;12(5):427-33 PMID: 11882296
  60. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
    Cancer Res. 2002 Mar 1;62(5):1559-66 PMID: 11888936
  61. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.
    Mol Cell Biol. 2002 May;22(9):3035-45 PMID: 11940661
  62. Interactions of phocein with nucleoside-diphosphate kinase, Eps15, and Dynamin I.
    J Biol Chem. 2002 May 24;277(21):18961-6 PMID: 11872741
  63. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement.
    J Biol Chem. 2002 Jun 7;277(23):20895-902 PMID: 11919189
  64. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
    J Biol Chem. 2002 Aug 30;277(35):32389-99 PMID: 12105213
  65. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11593-8 PMID: 12195017
  66. KSR, a novel protein kinase required for RAS signal transduction.
    Cell. 1995 Dec 15;83(6):879-88 PMID: 8521512
  67. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction.
    Cell. 1995 Dec 15;83(6):889-901 PMID: 8521513
  68. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans.
    Cell. 1995 Dec 15;83(6):903-13 PMID: 8521514
  69. Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.
    Br J Cancer. 1996 Mar;73(5):630-5 PMID: 8605098
  70. Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells.
    Int J Cancer. 1996 Feb 8;65(4):531-7 PMID: 8621239
  71. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
    J Biol Chem. 1996 Oct 11;271(41):25107-16 PMID: 8810265
  72. The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily.
    Biochem Biophys Res Commun. 1996 Oct 3;227(1):82-7 PMID: 8858107
  73. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
    Int J Cancer. 1997 Feb 20;74(1):102-11 PMID: 9036878
  74. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity.
    Cancer Chemother Pharmacol. 1997;40(1):60-4 PMID: 9137531
  75. Copurification of vimentin, energy metabolism enzymes, and a MER5 homolog with nucleoside diphosphate kinase. Identification of tissue-specific interactions.
    J Biol Chem. 1997 Jun 6;272(23):14690-4 PMID: 9169432
  76. Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).
    Clin Exp Metastasis. 1997 May;15(3):259-65 PMID: 9174127
  77. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres.
    Biochem Biophys Res Commun. 1998 Feb 13;243(2):342-8 PMID: 9480811
  78. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines.
    Br J Cancer. 1998 Sep;78(6):710-7 PMID: 9743288
  79. Differential expression and mutation of the ras family genes in human breast cancer.
    Biochem Biophys Res Commun. 1998 Oct 20;251(2):609-12 PMID: 9792821
  80. Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform.
    Int J Mol Med. 1998 Jul;2(1):65-8 PMID: 9854145
  81. KSR-1 binds to G-protein betagamma subunits and inhibits beta gamma-induced mitogen-activated protein kinase activation.
    J Biol Chem. 1999 Mar 19;274(12):7982-6 PMID: 10075696
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2005-02-00
Pages
1379-88
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC548014
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com